Cargando…
Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis
Proton pump inhibitors (PPIs) can directly interfere with osteoclastic function, induce hypergastrinemia, and inhibit calcium absorption, leading to reduced bone mineral density (BMD), a measure of bone metabolism that may be associated with the risk of fractures. The current study involves a system...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603342/ https://www.ncbi.nlm.nih.gov/pubmed/36294082 http://dx.doi.org/10.3390/ijerph192013501 |
_version_ | 1784817524107378688 |
---|---|
author | da Maia, Thuila Ferreira de Camargo, Bruna Gafo Pereira, Meire Ellen de Oliveira, Cláudia Sirlene Guiloski, Izonete Cristina |
author_facet | da Maia, Thuila Ferreira de Camargo, Bruna Gafo Pereira, Meire Ellen de Oliveira, Cláudia Sirlene Guiloski, Izonete Cristina |
author_sort | da Maia, Thuila Ferreira |
collection | PubMed |
description | Proton pump inhibitors (PPIs) can directly interfere with osteoclastic function, induce hypergastrinemia, and inhibit calcium absorption, leading to reduced bone mineral density (BMD), a measure of bone metabolism that may be associated with the risk of fractures. The current study involves a systematic review and meta-analysis aimed at assessing the relationship between prolonged use of PPI drugs and fractures in menopausal women. A systematic search and meta-analysis were performed on PubMed, Scopus, and Science Direct databases according to PRISMA guidelines. Two independent reviewers analyzed the articles. The five articles found in the databases, which met the eligibility criteria, covered participants who were menopausal women aged between 56 and 78.5 years, using or not using a PPI for a minimum of 12 months. All studies showed an increase in the rate of fractures related to using PPIs, as an outcome. Prolonged use of PPIs in menopausal women can affect bone metabolism and cause fractures. However, other factors, such as the use of other classes of drugs, obesity, low weight, poor diet, replacement hormones, and comorbidities, should also be considered for assessing the risk of fractures. |
format | Online Article Text |
id | pubmed-9603342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96033422022-10-27 Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis da Maia, Thuila Ferreira de Camargo, Bruna Gafo Pereira, Meire Ellen de Oliveira, Cláudia Sirlene Guiloski, Izonete Cristina Int J Environ Res Public Health Review Proton pump inhibitors (PPIs) can directly interfere with osteoclastic function, induce hypergastrinemia, and inhibit calcium absorption, leading to reduced bone mineral density (BMD), a measure of bone metabolism that may be associated with the risk of fractures. The current study involves a systematic review and meta-analysis aimed at assessing the relationship between prolonged use of PPI drugs and fractures in menopausal women. A systematic search and meta-analysis were performed on PubMed, Scopus, and Science Direct databases according to PRISMA guidelines. Two independent reviewers analyzed the articles. The five articles found in the databases, which met the eligibility criteria, covered participants who were menopausal women aged between 56 and 78.5 years, using or not using a PPI for a minimum of 12 months. All studies showed an increase in the rate of fractures related to using PPIs, as an outcome. Prolonged use of PPIs in menopausal women can affect bone metabolism and cause fractures. However, other factors, such as the use of other classes of drugs, obesity, low weight, poor diet, replacement hormones, and comorbidities, should also be considered for assessing the risk of fractures. MDPI 2022-10-19 /pmc/articles/PMC9603342/ /pubmed/36294082 http://dx.doi.org/10.3390/ijerph192013501 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review da Maia, Thuila Ferreira de Camargo, Bruna Gafo Pereira, Meire Ellen de Oliveira, Cláudia Sirlene Guiloski, Izonete Cristina Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis |
title | Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis |
title_full | Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis |
title_fullStr | Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis |
title_short | Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis |
title_sort | increased risk of fractures and use of proton pump inhibitors in menopausal women: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603342/ https://www.ncbi.nlm.nih.gov/pubmed/36294082 http://dx.doi.org/10.3390/ijerph192013501 |
work_keys_str_mv | AT damaiathuilaferreira increasedriskoffracturesanduseofprotonpumpinhibitorsinmenopausalwomenasystematicreviewandmetaanalysis AT decamargobrunagafo increasedriskoffracturesanduseofprotonpumpinhibitorsinmenopausalwomenasystematicreviewandmetaanalysis AT pereirameireellen increasedriskoffracturesanduseofprotonpumpinhibitorsinmenopausalwomenasystematicreviewandmetaanalysis AT deoliveiraclaudiasirlene increasedriskoffracturesanduseofprotonpumpinhibitorsinmenopausalwomenasystematicreviewandmetaanalysis AT guiloskiizonetecristina increasedriskoffracturesanduseofprotonpumpinhibitorsinmenopausalwomenasystematicreviewandmetaanalysis |